Identification of angiotensin II as a crucial regulator of cancer-induced extramedullary hematopoiesis raised the question whether angiotensin-converting enzyme (ACE) inhibitors, widely used to treat hypertension, could suppress heightened extramedullary monocyte production and subsequent macrophage accumulation in tumors (77). This evidence concerns the gene ACE and hypertensive disorder.